Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples

Liquid chromatography-tandem mass spectrometry was used to analyze plasma proteins of volunteers (control) and patients with glioblastoma multiform (GBM). A database search was pre-set with a variable post-translational modification (PTM): phosphorylation, acetylation or ubiquitination. There were n...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Petushkova, Natalia A., Zgoda, Victor G., Pyatnitskiy, Mikhail A., Larina, Olesya V., Teryaeva, Nadezhda B., Potapov, Alexander A., Lisitsa, Andrey V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5426747/
https://ncbi.nlm.nih.gov/pubmed/28493947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0177427
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak